|
Cash equivalents:
|
$ 8,757
|
|
Investments in securities:
|
$ 142,917,592
|
|
Dividends and interest receivable:
|
$ 293,978
|
|
Other assets:
|
$ 55,335
|
|
Total Assets:
|
$ 143,275,662
|
|
Grants approved for future payment:
|
$3,631,949
|
|
Accounts payable and accrued expenses:
|
$167,286
|
|
Deferred excise taxes:
|
$174,466
|
|
Total liabilities:
|
$3,973,701
|
|
Net assets:
|
$139,301,961
|
|
Total Liabilities and Net Assets
|
$143,275,662
|
|
Gain (loss) from investments:
|
$19,052,850
|
|
Investment related and other expenses:
|
$(837,904)
|
|
Net gain(loss) from investments:
|
$18,214,946
|
|
Grants approved:
|
$6,080,108
|
|
Grant support:
|
$1,159,704
|
|
Total grants approved / related expenses:
|
$7,239,812
|
|
Net Gain (Loss) for the period
|
$10,975,134
|
